130 related articles for article (PubMed ID: 6969624)
1. Vincristine in the etiology of toxicity of high-dose methotrexate therapy.
Ridgway D; Renholds DC; Neerhout RC; Wolff LJ
Cancer; 1980 Dec; 46(12):2571-2. PubMed ID: 6969624
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion vincristine and bleomycin with high dose methotrexate for resistant non-Hodgkin's lymphoma.
Hollister D; Silver RT; Gordon B; Coleman M
Cancer; 1982 Nov; 50(9):1690-4. PubMed ID: 6180819
[TBL] [Abstract][Full Text] [Related]
3. Continuous cisplatin infusion in combination with vincristine and high-dose methotrexate for advanced osteogenic sarcoma.
Gasparini M; Tondini C; Rottoli L; Roncoroni I
Am J Clin Oncol; 1987 Apr; 10(2):152-5. PubMed ID: 3471069
[TBL] [Abstract][Full Text] [Related]
4. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
[TBL] [Abstract][Full Text] [Related]
5. Safety of delayed leucovorin "rescue" following high-dose methotrexate in children.
Camitta BM; Holcenberg JS
Med Pediatr Oncol; 1978; 5(1):55-9. PubMed ID: 370536
[TBL] [Abstract][Full Text] [Related]
6. High dose methotrexate with citrovorum factor in adult resistant lymphoma.
Turman S; Coleman M; Silver RT; Pasmantier M
Cancer; 1977 Dec; 40(6):2823-8. PubMed ID: 338137
[TBL] [Abstract][Full Text] [Related]
7. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
Allen JC; Rosen G
Ann Neurol; 1978 May; 3(5):441-4. PubMed ID: 310278
[TBL] [Abstract][Full Text] [Related]
8. Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma: pre-surgical treatment of primary tumor and of overt pulmonary metastases.
Jaffe N; Frei E; Traggis D; Watts H
Cancer; 1977 Jan; 39(1):45-50. PubMed ID: 299828
[TBL] [Abstract][Full Text] [Related]
9. High-dose methotrexate with a safe rescue program.
Decker DA; Edmonson JH; Gilchrist GS; Kovach JS; Offord JR; Taylor WF
Oncology; 1981; 38(5):262-4. PubMed ID: 6973732
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
Jaffe N; Frei E; Traggis D; Bishop Y
N Engl J Med; 1974 Nov; 291(19):994-7. PubMed ID: 4606174
[No Abstract] [Full Text] [Related]
11. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.
Cohen HJ; Jaffe N
Cancer Chemother Pharmacol; 1978; 1(1):61-4. PubMed ID: 373909
[TBL] [Abstract][Full Text] [Related]
13. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Jaffe N
Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
[No Abstract] [Full Text] [Related]
14. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
[TBL] [Abstract][Full Text] [Related]
15. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
16. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with metastatic osteogenic sarcoma: a report from the Children's Cancer Study Group.
Morgan E; Baum E; Bleyer WA; Movassaghi N; Provisor A; Lampkin B; Lukens J; Griffin T; White H; Fryer C
Cancer Treat Rep; 1984 Apr; 68(4):661-4. PubMed ID: 6370429
[TBL] [Abstract][Full Text] [Related]
18. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
[No Abstract] [Full Text] [Related]
19. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
[TBL] [Abstract][Full Text] [Related]
20. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].
Janka GE; Wiesner H; Bidlingmaier F; Haas RJ
Klin Wochenschr; 1979 Apr; 57(8):411-6. PubMed ID: 313478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
